Dr. Tao , Mi-Hua
A receptor-binding domain-based nanoparticle vaccine elicits durable neutralizing antibody responses against SARS-CoV-2 and variants of concern
Emerging Microbes & Infections Dec 24, 2022
Numerous vaccines have been developed to address the current COVID-19 pandemic, but safety, cross-neutralizing ...